Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Mursleen, S."" wg kryterium: Autor


Tytuł :
PRS44 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS UMEC/VI IN PATIENTS WITH COPD: COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC
Autorzy :
Mursleen, S.
Pokaż więcej
Źródło :
In ISPOR Europe 2018: New Perspectives for Improving 21st Century Health Systems, Value in Health October 2018 21 Supplement 3:S411-S411
Czasopismo naukowe
Tytuł :
PRS46 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS FF/VI IN PATIENTS WITH COPD: COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC
Autorzy :
Schroeder, M.
Pokaż więcej
Źródło :
In ISPOR Europe 2018: New Perspectives for Improving 21st Century Health Systems, Value in Health October 2018 21 Supplement 3:S411-S412
Czasopismo naukowe
Tytuł :
PSY57 - Belimumab for the Treatment of Adults Living with Active Systemic Lupus Erythematosus: A Cost-Effectiveness Analysis in Canada
Autorzy :
Mursleen, S
Pokaż więcej
Źródło :
In ISPOR 2018 Baltimore, May 19-23, Value in Health May 2018 21 Supplement 1:S254-S255
Czasopismo naukowe
Tytuł :
Effect of Disease Activity on Organ Damage Progression in Systemic Lupus Erythematosus: University of Toronto Lupus Clinic Cohort.
Autorzy :
Urowitz MB; This study was funded by GlaxoSmithKline Inc. (GSK; study number 201390). M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; 2S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada; 3J.A.R. Terres, MD, GlaxoSmithKline Inc., Toronto, Ontario, Canada, and GlaxoSmithKline Inc., Philadelphia, Pennsylvania, USA. JART and SM are employees of GSK. AS was an employee of GSK at the time of the study. AS and JART hold stocks in GSK. SI was an employee of GSK during the development of the manuscript. MBU has received consulting fees and research grants from GSK, UCB, and Eli Lilly. DDG reports consulting for GSK, BMS, Janssen, UCB, and Eli Lilly. Address correspondence to Prof. M.B. Urowitz, Toronto Western Hospital, 399 Bathurst Street, 1E409, Toronto, ON M5T 2S8, Canada. Email: . Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 18, 2020.
Gladman DD; This study was funded by GlaxoSmithKline Inc. (GSK; study number 201390). M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; 2S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada; 3J.A.R. Terres, MD, GlaxoSmithKline Inc., Toronto, Ontario, Canada, and GlaxoSmithKline Inc., Philadelphia, Pennsylvania, USA. JART and SM are employees of GSK. AS was an employee of GSK at the time of the study. AS and JART hold stocks in GSK. SI was an employee of GSK during the development of the manuscript. MBU has received consulting fees and research grants from GSK, UCB, and Eli Lilly. DDG reports consulting for GSK, BMS, Janssen, UCB, and Eli Lilly. Address correspondence to Prof. M.B. Urowitz, Toronto Western Hospital, 399 Bathurst Street, 1E409, Toronto, ON M5T 2S8, Canada. Email: . Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 18, 2020.
Ibañez D; This study was funded by GlaxoSmithKline Inc. (GSK; study number 201390). M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; 2S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada; 3J.A.R. Terres, MD, GlaxoSmithKline Inc., Toronto, Ontario, Canada, and GlaxoSmithKline Inc., Philadelphia, Pennsylvania, USA. JART and SM are employees of GSK. AS was an employee of GSK at the time of the study. AS and JART hold stocks in GSK. SI was an employee of GSK during the development of the manuscript. MBU has received consulting fees and research grants from GSK, UCB, and Eli Lilly. DDG reports consulting for GSK, BMS, Janssen, UCB, and Eli Lilly. Address correspondence to Prof. M.B. Urowitz, Toronto Western Hospital, 399 Bathurst Street, 1E409, Toronto, ON M5T 2S8, Canada. Email: . Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 18, 2020.
Su J; This study was funded by GlaxoSmithKline Inc. (GSK; study number 201390). M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; 2S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada; 3J.A.R. Terres, MD, GlaxoSmithKline Inc., Toronto, Ontario, Canada, and GlaxoSmithKline Inc., Philadelphia, Pennsylvania, USA. JART and SM are employees of GSK. AS was an employee of GSK at the time of the study. AS and JART hold stocks in GSK. SI was an employee of GSK during the development of the manuscript. MBU has received consulting fees and research grants from GSK, UCB, and Eli Lilly. DDG reports consulting for GSK, BMS, Janssen, UCB, and Eli Lilly. Address correspondence to Prof. M.B. Urowitz, Toronto Western Hospital, 399 Bathurst Street, 1E409, Toronto, ON M5T 2S8, Canada. Email: . Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 18, 2020.
Mursleen S; This study was funded by GlaxoSmithKline Inc. (GSK; study number 201390). M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; 2S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada; 3J.A.R. Terres, MD, GlaxoSmithKline Inc., Toronto, Ontario, Canada, and GlaxoSmithKline Inc., Philadelphia, Pennsylvania, USA. JART and SM are employees of GSK. AS was an employee of GSK at the time of the study. AS and JART hold stocks in GSK. SI was an employee of GSK during the development of the manuscript. MBU has received consulting fees and research grants from GSK, UCB, and Eli Lilly. DDG reports consulting for GSK, BMS, Janssen, UCB, and Eli Lilly. Address correspondence to Prof. M.B. Urowitz, Toronto Western Hospital, 399 Bathurst Street, 1E409, Toronto, ON M5T 2S8, Canada. Email: . Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 18, 2020.
Sayani A; This study was funded by GlaxoSmithKline Inc. (GSK; study number 201390). M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; 2S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada; 3J.A.R. Terres, MD, GlaxoSmithKline Inc., Toronto, Ontario, Canada, and GlaxoSmithKline Inc., Philadelphia, Pennsylvania, USA. JART and SM are employees of GSK. AS was an employee of GSK at the time of the study. AS and JART hold stocks in GSK. SI was an employee of GSK during the development of the manuscript. MBU has received consulting fees and research grants from GSK, UCB, and Eli Lilly. DDG reports consulting for GSK, BMS, Janssen, UCB, and Eli Lilly. Address correspondence to Prof. M.B. Urowitz, Toronto Western Hospital, 399 Bathurst Street, 1E409, Toronto, ON M5T 2S8, Canada. Email: . Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 18, 2020.
Ross Terres JA; This study was funded by GlaxoSmithKline Inc. (GSK; study number 201390). M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; 2S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada; 3J.A.R. Terres, MD, GlaxoSmithKline Inc., Toronto, Ontario, Canada, and GlaxoSmithKline Inc., Philadelphia, Pennsylvania, USA. JART and SM are employees of GSK. AS was an employee of GSK at the time of the study. AS and JART hold stocks in GSK. SI was an employee of GSK during the development of the manuscript. MBU has received consulting fees and research grants from GSK, UCB, and Eli Lilly. DDG reports consulting for GSK, BMS, Janssen, UCB, and Eli Lilly. Address correspondence to Prof. M.B. Urowitz, Toronto Western Hospital, 399 Bathurst Street, 1E409, Toronto, ON M5T 2S8, Canada. Email: . Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 18, 2020.
Iczkovitz S; This study was funded by GlaxoSmithKline Inc. (GSK; study number 201390). M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; 2S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada; 3J.A.R. Terres, MD, GlaxoSmithKline Inc., Toronto, Ontario, Canada, and GlaxoSmithKline Inc., Philadelphia, Pennsylvania, USA. JART and SM are employees of GSK. AS was an employee of GSK at the time of the study. AS and JART hold stocks in GSK. SI was an employee of GSK during the development of the manuscript. MBU has received consulting fees and research grants from GSK, UCB, and Eli Lilly. DDG reports consulting for GSK, BMS, Janssen, UCB, and Eli Lilly. Address correspondence to Prof. M.B. Urowitz, Toronto Western Hospital, 399 Bathurst Street, 1E409, Toronto, ON M5T 2S8, Canada. Email: . Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication March 18, 2020.
Pokaż więcej
Źródło :
The Journal of rheumatology [J Rheumatol] 2020 Apr 01. Date of Electronic Publication: 2020 Apr 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada.
Autorzy :
Rampakakis E; From the JSS Medical Research, Montreal, Quebec, Canada.
Vaillancourt J; From the JSS Medical Research, Montreal, Quebec, Canada.
Mursleen S; GSK, Mississauga, Ontario, Canada.
Sampalis JS; From the JSS Medical Research, Montreal, Quebec, Canada.; McGill University, Montreal, Quebec, Canada.
Pokaż więcej
Źródło :
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2019 Mar; Vol. 38 (3), pp. 253-257.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Care Costs*
Patient Acceptance of Health Care*
Health Resources/*economics
Meningococcal Infections/*economics
Adolescent ; Adult ; Case-Control Studies ; Child ; Child, Preschool ; Female ; Health Resources/statistics & numerical data ; Hospital Costs ; Hospitalization/economics ; Humans ; Male ; Meningococcal Infections/epidemiology ; Middle Aged ; Ontario/epidemiology ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Equity issues were not fully addressed in Cochrane human immunodeficiency virus systematic reviews.
Autorzy :
Aves T; Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario, Canada L8S 4K1; Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, 50 Charlton Ave E, Hamilton, Ontario, Canada L8N 4A6.
Kredo T; Cochrane South Africa, South African Medical Research Council, Cape Town, PO Box 19070, Tygerberg 7505, South Africa.
Welch V; Centre for Global Health, Institute of Population Health, University of Ottawa, 43 Bruyère St, Annex E, Ottawa, Ontario, Canada K1N 5C8.
Mursleen S; Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario, Canada L8S 4K1.
Ross S; Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario, Canada L8S 4K1.
Zani B; Cochrane South Africa, South African Medical Research Council, Cape Town, PO Box 19070, Tygerberg 7505, South Africa; Centre for Evidence-Based Health Care, Department of Interdisciplinary Health Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 800, South Africa.
Motaze NV; Cochrane South Africa, South African Medical Research Council, Cape Town, PO Box 19070, Tygerberg 7505, South Africa; Centre for Evidence-Based Health Care, Department of Interdisciplinary Health Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 800, South Africa.
Quinlan L; Bruyère Continuing Care, Bruyère Research Institute, University of Ottawa, 43 Bruyère Street, Ottawa, Ontario, Canada K1N 5C8.
Mbuagbaw L; Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario, Canada L8S 4K1; Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, 50 Charlton Ave E, Hamilton, Ontario, Canada L8N 4A6. Electronic address: .
Pokaż więcej
Źródło :
Journal of clinical epidemiology [J Clin Epidemiol] 2017 Jan; Vol. 81, pp. 96-100. Date of Electronic Publication: 2016 Sep 29.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Health Status Disparities*
Review Literature as Topic*
HIV Infections/*epidemiology
Health Equity/*statistics & numerical data
Bibliometrics ; Female ; Humans ; Male ; Socioeconomic Factors
Czasopismo naukowe
Tytuł :
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
Autorzy :
Mbuagbaw L; Centre for the Development of Best Practices in Health (CDBPH), Yaoundé Central Hospital, Henri Dunant Avenue, PO Box 87, Yaoundé, Cameroon.; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
Mursleen S; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
Irlam JH; Primary Health Care Directorate, University of Cape Town, E47 OMB, Groote Schuur Hospital, Cape Town, Western Cape, South Africa, 7925.
Spaulding AB; Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, 2953 TERRACE DR, Bethesda, MD, USA, 20892.
Rutherford GW; Global Health Sciences, University of California, San Francisco, 50 Beale Street, Suite 1200, San Francisco, California, USA, 94105.
Siegfried N; Cape Town, South Africa.; Alcohol, Tobacco and Other Drug Research Unit, Medical Research Council, Francie van Zijl Drive, Tygerberg, South Africa, 7505.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2016 Dec 10; Vol. 12. Cochrane AN: CD004246. Date of Electronic Publication: 2016 Dec 10.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Benzoxazines/*therapeutic use
HIV Infections/*drug therapy
Nevirapine/*therapeutic use
Reverse Transcriptase Inhibitors/*therapeutic use
Adult ; Anti-HIV Agents/therapeutic use ; Benzoxazines/adverse effects ; Drug Therapy, Combination/methods ; HIV Infections/mortality ; HIV Infections/virology ; Humans ; Nevirapine/adverse effects ; Randomized Controlled Trials as Topic ; Reverse Transcriptase Inhibitors/adverse effects ; Viral Load/drug effects
Czasopismo naukowe
Tytuł :
Critical EPICOT items were absent in Cochrane human immunodeficiency virus systematic reviews: a bibliometric analysis.
Autorzy :
Mbuagbaw L; Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main St West, Hamilton, Ontario, Canada L8S4K1. Electronic address: .
Kredo T; South African Cochrane Centre, South African Medical Research Council, Francie van Zijl Drive, Parowvalley, 7505 Tygerberg, Cape Town, South Africa.
Welch V; Centre for Global Health, Institute of Population Health, University of Ottawa, Ottawa, 43 Bruyère St, Annex E, K1N 5C8, Ontario, Canada.
Mursleen S; Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main St West, Hamilton, Ontario, Canada L8S4K1.
Ross S; Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main St West, Hamilton, Ontario, Canada L8S4K1.
Zani B; South African Cochrane Centre, South African Medical Research Council, Francie van Zijl Drive, Parowvalley, 7505 Tygerberg, Cape Town, South Africa; Centre for Evidence-Based Health Care, Department of Interdisciplinary Health Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 800, South Africa.
Motaze NV; South African Cochrane Centre, South African Medical Research Council, Francie van Zijl Drive, Parowvalley, 7505 Tygerberg, Cape Town, South Africa; Centre for Evidence-Based Health Care, Department of Interdisciplinary Health Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town 800, South Africa.
Quinlan L; Bruyère Continuing Care, Bruyère Research Institute, University of Ottawa, Ottawa, 43 Bruyère Street, K1N 5C8, Ontario, Canada.
Pokaż więcej
Źródło :
Journal of clinical epidemiology [J Clin Epidemiol] 2016 Jun; Vol. 74, pp. 66-72. Date of Electronic Publication: 2015 Nov 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Bibliometrics*
HIV Infections/*epidemiology
Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies